Evidence map›Paper›PMID 17914176›Full record

ArticleMolecular biotechnology2007

Expression and molecular characterization of ZmMYB-IF35 and related R2R3-MYB transcription factors.

George F Heine, Vinod Malik, Anusha P Dias, Erich Grotewold

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

George F HeineDepartment of Plant Cellular and Molecular Biology and Plant Biotechnology Center, The Ohio State University, Columbus, OH, 43210, USA.
Vinod Malik
Anusha P Dias
Erich Grotewold
The Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

R2R3-MYB transcription factors play many important roles in higher plants including the regulation of secondary metabolism, the control of cell shape, and in the response to various stress conditions. In spite of their large number and significance, very few of these genes have been functionally characterized in monocots. Here, we describe the characterization of ZmMYB-IF35 from maize. Using GAL4 fusion constructs, we show that ZmMYB-IF35 possesses the ability to bind DNA in a sequence specific manner and activate transcription in yeast. We also show that ZmMYB-IF35 is capable of binding to the a1 promoter in planta, but it is not sufficient for activation of a1 transcription. Interestingly, a chimeric protein consisting of the MYB domain from ZmMYB-IF35 and the non-MYB C-terminal region of P1, a closely related R2R3-MYB protein, activated transcription from the a1 promoter in planta, suggesting that regions outside the conserved R2R3-MYB domain contribute to regulatory specificity. In situ hybridization experiments demonstrate that ZmMYB-IF35 expresses primarily in epidermal and vascular cells, while its rice ortholog, OsMYB-IF, displays a broad expression pattern in aerial parts of the plant. Together, our results provide novel insights on the participation of ZmMYB-IF35 and related genes in the regulation of secondary metabolic pathways in the grasses.

Indexed as

Gene ExpressionGene Expression Regulation, PlantAmino Acid SequenceDNA, PlantIn Situ HybridizationMolecular Sequence DataPhylogenyPlant ProteinsProtein BindingRNA, MessengerSequence AlignmentTranscriptional ActivationTranscription FactorsZea maysDNA, PlantPlant ProteinsRNA, MessengerTranscription Factors

Identifiers

PMID17914176
OpenAlexW2067967756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.